Stay updated on Nivolumab with Bevacizumab in Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab with Bevacizumab in Glioblastoma Clinical Trial page.

Latest updates to the Nivolumab with Bevacizumab in Glioblastoma Clinical Trial page
- Check5 days agoChange DetectedThe page adds new help and navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and indicates that no participants are being recruited. The Intervention/Treatment label is updated from 'Intervention / Treatment' and the revision version changes to v3.6.0.SummaryDifference0.4%

- Check12 days agoChange DetectedThe page now displays Revision: v3.5.5, indicating an updated version is in effect. This update reflects a version control change rather than a modification to the study details or navigation.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedRevision: v3.5.4 was added, indicating a software version update in the page footer. This update does not modify the study content or visible functionality.SummaryDifference0.1%

- Check55 days agoChange DetectedThis change updates the ClinicalTrials.gov page’s UI/release revision marker from v3.5.2 to v3.5.3 without altering the displayed study details.SummaryDifference0.1%

- Check62 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2. No study content or user-facing information appears to have changed.SummaryDifference0.1%

- Check91 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 from the revision history.SummaryDifference0.1%

Stay in the know with updates to Nivolumab with Bevacizumab in Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab with Bevacizumab in Glioblastoma Clinical Trial page.